Imaging software developer Mirada Medical will form part of a consortium receiving 50 million pounds (56 million euros) in new funding from the U.K. government as part of its drive to expedite the development and adoption of artificial intelligence (AI) in healthcare and the National Health Service (NHS).
Mirada already developed deep-learning applications for radiotherapy planning. The company will bring its expertise and practical experience to projects hosted by Kings College London and the University of Oxford, two of the five centers funded through Wave 2 of the Industrial Strategy Challenge Fund's Data to Early Diagnosis and Precision Medicine initiative.
Mirada will partner with the London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare, led by Kings College London, and will work with Guys & St Thomas hospital. Mirada will build on its DLCExpert radiation therapy planning application to demonstrate how deep-learning technologies can be used to improve patient care.
Mirada will also partner with the University of Oxford's National Consortium of Intelligent Medical Imaging (NCIMI) to investigate the role AI and deep learning can play in diagnostic nuclear medicine. The company will build on its established partnership with the Alliance Medical Group and the NHS PET scanning program, in which its software is already used to read more than half of the PET/CT scans in England and Wales.
